Two-year efficacy of varenicline tartrate and counselling for inpatient smoking cessation (STOP study): A randomized controlled clinical trial.

Kristin V Carson-ChahhoudBrian J SmithMatthew J PetersMalcolm P BrinnFaisal AmeerKuljit SinghRobert FitridgeSimon A KoblarJim JannesAntony J VealeSharon GoldsworthyKhin HninAdrian J Esterman

Published in: PloS one (2020)

This is the first study to examine the efficacy and safety of varenicline tartrate over 104 weeks within any setting. Varenicline tartrate plus Quitline-counselling was found to be an effective opportunistic treatment when initiated for inpatient smokers who had been admitted with tobacco-related disease.

Keyphrases

smoking cessation
replacement therapy
mental health
human immunodeficiency virus
drug induced